These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35389345)

  • 1. Prevalence and outcomes of stent thrombosis with in-stent calcified nodules: substudy from the REAL-ST registry.
    Takahashi Y; Otake H; Kuramitsu S; Ohya M; Horie K; Kawamoto H; Yamanaka F; Natsuaki M; Shiomi H; Nakazawa G; Ando K; Kadota K; Saito S; Kimura T
    EuroIntervention; 2022 Oct; 18(9):749-758. PubMed ID: 35389345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors and Outcomes of Recurrent Drug-Eluting Stent Thrombosis: Insights From the REAL-ST Registry.
    Enomoto S; Kuramitsu S; Shinozaki T; Ohya M; Otake H; Yamanaka F; Shiomi H; Natsuaki M; Nakazawa G; Ando K; Kadota K; Saito S; Tamura T; Kimura T;
    J Am Heart Assoc; 2021 May; 10(9):e018972. PubMed ID: 33870710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients.
    Tada T; Byrne RA; Simunovic I; King LA; Cassese S; Joner M; Fusaro M; Schneider S; Schulz S; Ibrahim T; Ott I; Massberg S; Laugwitz KL; Kastrati A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1267-74. PubMed ID: 24355117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-Year Clinical Outcomes After Drug-Eluting Stent Implantation Following Rotational Atherectomy for Heavily Calcified Lesions.
    Jinnouchi H; Kuramitsu S; Shinozaki T; Hiromasa T; Kobayashi Y; Takeji Y; Miura M; Masuda H; Matsumura Y; Yamaji Y; Sakakura K; Domei T; Soga Y; Hyodo M; Shirai S; Ando K
    Circ J; 2018 Mar; 82(4):983-991. PubMed ID: 28890526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors and Long-Term Clinical Outcomes of Second-Generation Drug-Eluting Stent Thrombosis.
    Kuramitsu S; Ohya M; Shinozaki T; Otake H; Horie K; Kawamoto H; Yamanaka F; Natsuaki M; Shiomi H; Nakazawa G; Ando K; Kadota K; Saito S; Kimura T
    Circ Cardiovasc Interv; 2019 Jun; 12(6):e007822. PubMed ID: 31177822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Efficacy and Safety between First- and Second-Generation Drug-Eluting Stents in Patients with Acute Coronary Syndrome.
    Ma YL; Tang XF; Yao Y; Xu N; Song Y; Jiang P; Xu JJ; Wang HH; Jiang L; Liu R; Zhao XY; Chen J; Gao Z; Qiao SB; Yang YJ; Gao RL; Xu B; Yuan JQ
    Chin Med J (Engl); 2018 Jun; 131(12):1397-1405. PubMed ID: 29893356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).
    Waksman R; Kirtane AJ; Torguson R; Cohen DJ; Ryan T; Räber L; Applegate R; Waxman S; Gordon P; Kaneshige K; Leon MB;
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1093-102. PubMed ID: 25240540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stent thrombosis with second- versus first-generation drug-eluting stents in real-world percutaneous coronary intervention: analysis of 3806 consecutive procedures from a large-volume single-center prospective registry.
    Dores H; Raposo L; Campante Teles R; Machado C; Leal S; Araújo Gonçalves P; Mesquita Gabriel H; Sousa Almeida M; Mendes M
    J Invasive Cardiol; 2013 Jul; 25(7):330-6. PubMed ID: 23813060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of calcified nodule in patients with heavily calcified lesions requiring rotational atherectomy.
    Morofuji T; Kuramitsu S; Shinozaki T; Jinnouchi H; Sonoda S; Domei T; Hyodo M; Shirai S; Ando K
    Catheter Cardiovasc Interv; 2021 Jan; 97(1):10-19. PubMed ID: 32259392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Everolimus-eluting stents versus sirolimus- or paclitaxel-eluting stents: two-year results from the Guthrie Health Off-Label Stent (GHOST) registry.
    Harjai KJ; Kondareddy S; Pinkosky B; Harjai N; Orshaw P; Boura J
    J Interv Cardiol; 2013 Apr; 26(2):153-62. PubMed ID: 23363439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes following coronary drug-eluting- and bare-metal-stent implantation.
    Auer J; Leitner A; Berent R; Lamm G; Lassnig E; Krennmair G
    Atherosclerosis; 2010 Jun; 210(2):503-9. PubMed ID: 20060973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between drug-eluting and bare metal stent on ST-elevation myocardial infarction outcome: should second-generation drug-eluting stent be preferred?
    Giglioli C; Cecchi E; Vladi L; Stolcova M; Valente S; Meucci F; Baldereschi GJ; Chiostri M; Romano SM; Gensini GF; Barchielli A; Balzi D
    J Cardiol; 2014 Apr; 63(4):296-301. PubMed ID: 24365386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stent-Related Adverse Events as Related to Dual Antiplatelet Therapy in First- vs Second-Generation Drug-Eluting Stents.
    Yoshikawa Y; Shiomi H; Morimoto T; Takeji Y; Matsumura-Nakano Y; Yamamoto K; Yamamoto E; Kato ET; Watanabe H; Saito N; Domei T; Tada T; Nawada R; Onodera T; Suwa S; Tamura T; Ishii K; Ando K; Furukawa Y; Kadota K; Nakagawa Y; Kimura T;
    JACC Asia; 2021 Dec; 1(3):345-356. PubMed ID: 36341224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiographic predictors of 2-year stent thrombosis in patients receiving drug-eluting stents: Insights from the ADAPT-DES study.
    Généreux P; Redfors B; Witzenbichler B; Maehara A; Yadav M; Weisz G; Francese DP; Parvataneni R; Brener SJ; Mehran R; Kirtane AJ; Stone GW
    Catheter Cardiovasc Interv; 2017 Jan; 89(1):26-35. PubMed ID: 26813732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stent thrombosis in new-generation drug-eluting stents in patients with STEMI undergoing primary PCI: a report from SCAAR.
    Sarno G; Lagerqvist B; Nilsson J; Frobert O; Hambraeus K; Varenhorst C; Jensen UJ; Tödt T; Götberg M; James SK
    J Am Coll Cardiol; 2014 Jul; 64(1):16-24. PubMed ID: 24998123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term clinical outcome of rotational atherectomy followed by drug-eluting stent implantation in complex calcified coronary lesions.
    Abdel-Wahab M; Baev R; Dieker P; Kassner G; Khattab AA; Toelg R; Sulimov D; Geist V; Richardt G
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):285-91. PubMed ID: 22431433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of early versus late clopidogrel discontinuation on stent thrombosis following percutaneous coronary intervention with first- and second-generation drug-eluting stents.
    Loh JP; Torguson R; Pendyala LK; Omar A; Chen F; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2014 Jun; 113(12):1968-76. PubMed ID: 24767975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second-generation versus first-generation drug-eluting stents for the treatment of patients with acute coronary syndromes and obstructive coronary artery disease.
    Machado C; Raposo L; Dores H; Leal S; Campante Teles R; de Araújo Gonçalves P; Mesquita Gabriel H; Almeida M; Mendes M
    Coron Artery Dis; 2014 May; 25(3):208-14. PubMed ID: 24419038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fixed and Modifiable Correlates of Drug-Eluting Stent Thrombosis From a Large All-Comers Registry: Insights From ADAPT-DES.
    Brodie BR; Garg A; Stuckey TD; Kirtane AJ; Witzenbichler B; Maehara A; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Mehran R; Parvataneni R; Stone GW
    Circ Cardiovasc Interv; 2015 Oct; 8(10):. PubMed ID: 26415600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First- Versus Second-Generation Drug-Eluting Stents in Acute Coronary Syndromes (Katowice-Zabrze Registry).
    Kawecki D; Morawiec B; Dola J; Wanha W; Smolka G; Pluta A; Marcinkiewicz K; Ochała A; Nowalany-Kozielska E; Wojakowski W
    Arq Bras Cardiol; 2016 May; 106(5):373-81. PubMed ID: 27058257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.